Heterotopic Ossification: A Comprehensive Review

Carolyn Meyers, Jeffrey Lisiecki, Sarah Miller, Adam Levin, Laura Fayad, Catherine Ding, Takashi Sono, Edward McCarthy, Benjamin Levi, Aaron W James, Carolyn Meyers, Jeffrey Lisiecki, Sarah Miller, Adam Levin, Laura Fayad, Catherine Ding, Takashi Sono, Edward McCarthy, Benjamin Levi, Aaron W James

Abstract

Heterotopic ossification (HO) is a diverse pathologic process, defined as the formation of extraskeletal bone in muscle and soft tissues. HO can be conceptualized as a tissue repair process gone awry and is a common complication of trauma and surgery. This comprehensive review seeks to synthesize the clinical, pathoetiologic, and basic biologic features of HO, including nongenetic and genetic forms. First, the clinical features, radiographic appearance, histopathologic diagnosis, and current methods of treatment are discussed. Next, current concepts regarding the mechanistic bases for HO are discussed, including the putative cell types responsible for HO formation, the inflammatory milieu and other prerequisite "niche" factors for HO initiation and propagation, and currently available animal models for the study of HO of this common and potentially devastating condition. © 2019 The Authors. JBMR Plus published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research.

Keywords: ECTOPIC BONE; FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; HETEROTOPIC BONE; MYOSITIS OSSIFICANS.

Figures

Figure 1
Figure 1
Radiographic appearance of heterotopic ossification (HO). (A) Lateral radiograph of the knee, demonstrating a posterior, well‐circumscribed soft tissue mass with peripheral radiodensity characteristic of HO (white arrowhead). A history of blunt trauma to the area was provided. (B) Lateral radiograph of the elbow, demonstrating an anterior, well‐circumscribed, and heavily ossified soft tissue mass (white arrowhead). Peripheral radiodensity is less apparent in this example. A history of antecedent local trauma was present. (C) Later, HO may form focal or even more diffuse connections to the underlying bone. In this unusual case, a well‐demarcated osseous lesion (red arrowhead) has a broad base of attachment (white arrowhead) to the posterior aspect of the distal femur. This lesion came to clinical attention due to local discomfort but without a history of trauma. (D) In severe cases, complete fusion (ankylosis) of the joint is observed, as is the case in the CT reconstruction with broad‐based connections of bone from the proximal femur to the ilium (white arrowheads). Clinical data not available. (E) Lateral radiograph of the ankle, demonstrating ossification of the Achilles tendon (white arrowhead). A history of local trauma was provided. (F) In this case of genetic heterotopic bone (fibrodysplasia ossificans progressiva), extensive ossification (asterisks) is present within the subcutis, muscle, and deep soft tissue around the proximal femur.
Figure 2
Figure 2
Histologic appearance of heterotopic ossification (HO) by H&E staining. (A) Whole‐mount, tile scan image of early HO, demonstrating a highly cellular lesion with multifocal areas of wispy osteoid formation. This enlarging intramuscular lesion was removed from the back of a 15‐year‐old patient, with no known history of local trauma. (B) Representative central area, which demonstrates a “granulation tissue‐like” spindle cell proliferation without bone. Magnification ×40. (C) Representative peripheral area, demonstrating woven bone (arrowheads) and compressed fibrous pseudocapsule on the lesions’ exterior (asterisk). Magnification ×40. (D) Mature HO, often received in fragments owing to the density of the bone tissue. Whole‐mount, tile scan image. Here, increased quantity of thickened, lamellar bone is observed. Longstanding intramuscular mass was excised from the forearm of a 31‐year‐old patient. No history of trauma or other predisposing factor to HO was obtained in this case. (E) Representative central area, with lamellar bone trabeculae with bone‐lining cells (arrowheads) with intervening fibrous tissue resembling fibrotic marrow (asterisk). Magnification ×20. (F) Representative peripheral area, with thickened lamellar bone bearing resemblance to native cortical bone. Magnification ×40. Red scale bars = 2 mm. Black scale bars = 25 µm.
Figure 3
Figure 3
Histologic appearance of early/evolving heterotopic ossification (HO) by H&E staining. (A) The lesion is highly cellular and composed of spindle cells and scattered inflammatory cells. In the upper right, heterotopic bone formation is observed, with prominent osteoblast rimming (arrowheads). Note the intramembranous origin of bone in this case, which forms directly from stromal cell condensates. Magnification ×10. (B) Higher magnifications demonstrate the spindle cell proliferation in areas without bone formation. A cellular proliferation of spindled to ovoid cells are set in a variably edematous to fibrous stroma, with slender and elongated capillary‐type vessels (arrowheads) and a background of inflammatory cells (circles). No frank nuclear atypia or atypical mitotic figures are found. Magnification ×40. (C) A gradual continuum of woven bone (left) to more mature lamellar bone (right) is often observed in cases of nongenetic HO, which in an extraskeletal location is pathognomonic for HO. Magnification ×4. (D) Prominent bone lining osteoblasts are found (black arrowheads) in this example of HO. Also present in this image is the fibrous capsule around the periphery of the lesion (lower right), which often houses thick‐walled feeder vessels (red arrowhead). Magnification ×10. Images from parts A, B, and D are taken from the same case: a 6‐year‐old patient with an intramuscular pelvic mass and no additional clinical history. Images from C are from a 12‐year‐old patient with an intramuscular paraspinal mass. No additional clinical history available. Black scale bar = 100 µm. Red scale bar = 25 µm.
Figure 4
Figure 4
Histologic appearance of mature/late‐stage heterotopic ossification HO by H&E staining. (A) Appearance of mature HO, with thickened peripheral bone (black arrowheads), interior fatty marrow cavity (black asterisk), and foci of endochondral ossification (red arrowhead). (B) A neo‐cortex develops with elements resembling native cortical bone. Note an adipocyte‐rich interior on the left‐hand side of the image. (C) Focal metaplastic cartilage and endochondral ossification within this case are present. (D) In less common instances, sclerotic bone may develop, as seen in an osteoma. Images from A–C obtained from a 27‐year‐old patient with ossified soft tissue mass of the foot, with history of antecedent trauma; D obtained from a 66‐year‐old patient with an ossified soft tissue mass of the foot. Antecedent trauma as well as a history of previous resections was provided. All prior resections contained heterotopic bone. Red scale bars = 2 mm. Black scale bars = 50 µm.
Figure 5
Figure 5
Examples of HO post arthroplasty or spinal cord injury (neurogenic HO). (A) Flocculent radiodensity representing developing HO superior to the greater trochanter (arrowhead) in a post‐arthroplasty patient. (B) Massive and bilateral, peri‐articular HO in an immobilized patient with spinal cord injury.

References

    1. Dorfman HD, Czerniak B. Bone tumors: Maryland Heights, MO: Mosby; 1998.
    1. Ackerman LV. Extra‐osseous localized non‐neoplastic bone and cartilage formation (so‐called myositis ossificans): clinical and pathological confusion with malignant neoplasms. J Bone Joint Surg Am. 1958;40‐A(2):279–98.
    1. de Silva MV, Reid R. Myositis ossificans and fibroosseous pseudotumor of digits: a clinicopathological review of 64 cases with emphasis on diagnostic pitfalls. Int J Surg Pathol. 2003;11 (3):187–95.
    1. Nuovo MA, Norman A, Chumas J, Ackerman LV. Myositis ossificans with atypical clinical, radiographic, or pathologic findings: a review of 23 cases. Skeletal Radiol. 1992;21 (2):87–101.
    1. Rosenberg AE. Pseudosarcomas of soft tissue. Arch Pathol Lab Med. 2008;132(4):579–86.
    1. Sumiyoshi K, Tsuneyoshi M, Enjoji M. Myositis ossificans. A clinicopathologic study of 21 cases. Acta Pathol Jpn. 1985;35 (5):1109–22.
    1. Brooker AF, Bowerman JW, Robinson RA, Riley LH Jr. Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Joint Surg Am. 1973;55 (8):1629–32.
    1. Bedi A, Zbeda RM, Bueno VF, Downie B, Dolan M, Kelly BT. The incidence of heterotopic ossification after hip arthroscopy. Am J Sports Med. 2012;40 (4):854–63.
    1. Spinarelli A, Patella V, Petrera M, Abate A, Pesce V, Patella S. Heterotopic ossification after total hip arthroplasty: our experience. Musculoskelet Surg. 2011;95 (1):1–5.
    1. Hong CC, Nashi N, Hey HW, Chee YH, Murphy D. Clinically relevant heterotopic ossification after elbow fracture surgery: a risk factors study. Orthop Traumatol Surg Res. 2015;101 (2):209–13.
    1. Sandeep KN, Suresh G, Gopisankar B, Abhishek N, Sujiv A. Does excision of heterotopic ossification of the elbow result in satisfactory patient‐rated outcomes? Malays Orthop J. 2017;11(1):35–40.
    1. Forsberg JA, Pepek JM, Wagner S, et al. Heterotopic ossification in high‐energy wartime extremity injuries: prevalence and risk factors. J Bone Joint Surg Am. 2009;91 (5):1084–91.
    1. Teasell RW, Mehta S, Aubut JL, et al. A systematic review of the therapeutic interventions for heterotopic ossification after spinal cord injury. Spinal Cord. 2010;48 (7):512–21.
    1. Engber WD, Reynen P. Post‐burn heterotopic ossification at the elbow. Iowa Orthop J. 1994;14:38–41.
    1. Daniels CM, Pavey GJ, Arthur J, Noller M, Forsberg JA, Potter BK. Has the proportion of combat‐related amputations that develop heterotopic ossification increased? J Orthop Trauma. 2018;32 (6):283–7.
    1. Hoch B, Montag A. Reactive bone lesions mimicking neoplasms. Semin Diagn Pathol. 2011; 28 (1):102–12.
    1. Mavrogenis AF, Soucacos PN, Papagelopoulos PJ. Heterotopic ossification revisited. Orthopedics. 2011;34 (3):177.
    1. Conner GA, Duffy M. Myositis ossificans: a case report of multiple recurrences following third molar extractions and review of the literature. J Oral Maxillofac Surg. 2009;67 (4):920–6.
    1. Patel S, Richards A, Trehan R, Railton GT. Post‐traumatic myositis ossificans of the sternocleidomastoid following fracture of the clavicle: a case report. Cases J. 2008;1(1):413.
    1. Eckardt JJ, Ivins JC, Perry HO, Unni KK. Osteosarcoma arising in heterotopic ossification of dermatomyositis: case report and review of the literature. Cancer. 1981;48 (5):1256–61.
    1. Botzoris VG, Argyropoulou MI, Voulgari PV, Zikou AK, Drosos AA. Heterotopic ossification in systemic sclerosis. Scand J Rheumatol. 2009;38 (4):317–9.
    1. Chaudhry IH, Kazakov DV, Michal M, Mentzel T, Luzar B, Calonje E. Fibro‐osseous pseudotumor of the digit: a clinicopathological study of 17 cases. J Cutan Pathol. 2010;37 (3):323–9.
    1. McCarthy EF, Sundaram M. Heterotopic ossification: a review. Skeletal Radiol. 2005;34 (10):609–19.
    1. Pignolo RJ, Shore EM, Kaplan FS. Fibrodysplasia ossificans progressiva: clinical and genetic aspects. Orphanet J Rare Dis. 2011;6:80.
    1. Christofi T, Raptis DA, Kallis A, Ambasakoor F. True trilineage haematopoiesis in excised heterotopic ossification from a laparotomy scar: report of a case and literature review. Ann R Coll Surg Engl. 2008;90 (5):W12–4.
    1. Katz LD, Lindskog D, Eisen R. Neuritis ossificans of the tibial, common peroneal and lateral sural cutaneous nerves. J Bone Joint Surg Br. 2011;93 (7):992–4.
    1. Hashash JG, Zakhary L, Aoun EG, Refaat M. Heterotopic mesenteric ossification. Colorectal Dis. 2012;14 (1):e29–30.
    1. Tran L, Stein N, Miller S. Fibrodysplasia ossificans progressiva: early diagnosis is critical yet challenging. J Pediatr. 2010;157 (5):860 e1.
    1. Kaplan FS, Le Merrer M, Glaser DL, et al. Fibrodysplasia ossificans progressiva. Best Pract Res Clin Rheumatol. 2008;22 (1):191–205.
    1. Kaplan FS, Xu M, Glaser DL, et al. Early diagnosis of fibrodysplasia ossificans progressiva. Pediatrics. 2008;121 (5):e1295–300.
    1. Nakashima Y, Haga N, Kitoh H, et al. Deformity of the great toe in fibrodysplasia ossificans progressiva. J Orthop Sci. 2010;15 (6):804–9.
    1. Shore EM. Fibrodysplasia ossificans progressiva: a human genetic disorder of extraskeletal bone formation, or how does one tissue become another? Wiley Interdiscip Rev Dev Biol. 2012;1 (1):153–65.
    1. Glaser DL, Rocke DM, Kaplan FS. Catastrophic falls in patients who have fibrodysplasia ossificans progressiva. Clin Orthop Relat Res. 1998(346):110–6.
    1. Kaplan FS, Zasloff MA, Kitterman JA, Shore EM, Hong CC, Rocke DM. Early mortality and cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva. J Bone Joint Surg Am. 2010;92 (3):686–91.
    1. Pignolo RJ, Kaplan FS. Clinical staging of fibrodysplasia ossificans progressiva (FOP). Bone. 2018;109:111–4.
    1. Wentworth KL, Bigay K, Chan TV, et al. Clinical‐pathological correlations in three patients with fibrodysplasia ossificans progressiva. Bone. 2018;109:104–10.
    1. Wang H, Behrens EM, Pignolo RJ, Kaplan FS. ECSIT links TLR and BMP signaling in FOP connective tissue progenitor cells. Bone. 2018;109:201–9.
    1. Wang H, Shore EM, Pignolo RJ, Kaplan FS. Activin A amplifies dysregulated BMP signaling and induces chondro‐osseous differentiation of primary connective tissue progenitor cells in patients with fibrodysplasia ossificans progressiva (FOP). Bone. 2018;109:218–24.
    1. Culbert AL, Chakkalakal SA, Theosmy EG, Brennan TA, Kaplan FS, Shore EM. Alk2 regulates early chondrogenic fate in fibrodysplasia ossificans progressiva heterotopic endochondral ossification. Stem Cells. 2014;32 (5):1289–300.
    1. Barruet E, Morales BM, Lwin W, et al. The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell‐derived endothelial cell formation and collagen production through BMP‐mediated SMAD1/5/8 signaling. Stem Cell Res Ther. 2016;7 (1):115.
    1. Kaplan FS, Craver R, MacEwen GD, et al. Progressive osseous heteroplasia: a distinct developmental disorder of heterotopic ossification. Two new case reports and follow‐up of three previously reported cases. J Bone Joint Surg Am. 1994;76 (3):425–36.
    1. Shore EM, Ahn J, Jan de Beur S, et al. Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia. N Engl J Med. 2002;346(2):99–106.
    1. Fischer JA, Egert F, Werder E, Born W. An inherited mutation associated with functional deficiency of the alpha‐subunit of the guanine nucleotide‐binding protein Gs in pseudo‐ and pseudopseudohypoparathyroidism. J Clin Endocrinol Metab. 1998;83 (3):935–8.
    1. Kransdorf MJ, Meis JM. From the archives of the AFIP. Extraskeletal osseous and cartilaginous tumors of the extremities. Radiographics. 1993;13 (4):853–84.
    1. O'Brien EJ, Frank CB, Shrive NG, Hallgrímsson B, Hart DA. Heterotopic mineralization (ossification or calcification) in tendinopathy or following surgical tendon trauma. Int J Exp Pathol. 2012;93 (5):319–31.
    1. Sanyal S, Atwal SS, Mondal D, Garga UC. Radiographic patterns of soft tissue calcinosis in juvenile dermatomyositis and its clinical implications. J Clin Diagn Res. 2014;8 (12):RD08–11.
    1. Kaplan FS, Shore EM. Progressive osseous heteroplasia. J Bone Miner Res. 2000;15 (11):2084–94.
    1. Tyler P, Saifuddin A. The imaging of myositis ossificans. Semin Musculoskelet Radiol. 2010;14 (2):201–16.
    1. Kransdorf MJ, Meis JM, Jelinek JS. Myositis ossificans: MR appearance with radiologic‐pathologic correlation. AJR Am J Roentgenol. 1991;157 (6):1243–8.
    1. Cvitanic O, Sedlak J. Acute myositis ossificans. Skeletal Radiol. 1995;24 (2):139–41.
    1. Hastings H 2nd, Graham TJ. The classification and treatment of heterotopic ossification about the elbow and forearm. Hand Clin. 1994;10(3):417–37.
    1. Agrawal K, Bhattacharya A, Harisankar CN, et al. [18F]Fluoride and [18F]fluorodeoxyglucose PET/CT in myositis ossificans of the forearm. Eur J Nucl Med Mol Imaging. 2011;38 (10):1956.
    1. Eekhoff EMW, Botman E, Coen Netelenbos J, et al. [18F]NaF PET/CT scan as an early marker of heterotopic ossification in fibrodysplasia ossificans progressiva. Bone. 2018;109:143–6.
    1. Deryk S, Goethals L, Vanhove C, et al. Imaging characteristics of heterotopic mesenteric ossification on FDG PET and Tc‐99m bone SPECT. Clin Nucl Med. 2008;33(7):496–9.
    1. Wale DJ, Wong KK, Savas H, Kandathil A, Piert M, Brown RK. Extraosseous Findings on bone scintigraphy using fusion SPECT/CT and correlative imaging. AJR Am J Roentgenol. 2015;205 (1):160–72.
    1. Honjo H, Kumagai Y, Ishiguro T, et al. Heterotopic mesenteric ossification after a ruptured abdominal aortic aneurism: case report with a review of literatures. Int Surg. 2014;99 (4):479–84.
    1. Argyropoulou MI, Kostandi E, Kosta P, et al. Heterotopic ossification of the knee joint in intensive care unit patients: early diagnosis with magnetic resonance imaging. Crit Care. 2006;10 (5):R152.
    1. Cassar‐Pullicino VN, McClelland M, Badwan DA, McCall IW, Pringle RG, el Masry W. Sonographic diagnosis of heterotopic bone formation in spinal injury patients. Paraplegia. 1993;31(1):40–50.
    1. Peterson JR, Okagbare PI, De La Rosa S, et al. Early detection of burn induced heterotopic ossification using transcutaneous Raman spectroscopy. Bone. 2013;54(1):28–34.
    1. Perosky JE, Peterson JR, Eboda ON, et al. Early detection of heterotopic ossification using near‐infrared optical imaging reveals dynamic turnover and progression of mineralization following Achilles tenotomy and burn injury. J Orthop Res. 2014;32(11):1416–23.
    1. Stefanidis K, Brindley P, Ramnarine R, et al. Bedside ultrasound to facilitate early diagnosis and ease of follow‐up in neurogenic heterotopic ossification: a pilot study from the intensive care unit. J Head Trauma Rehabil. 2017;32 (6):E54– E8.
    1. Hoda SA. Enzinger and Weiss's soft tissue tumors, 6th edition. Adv Anat Pathol. 2014;21(3):216.
    1. Cocks M, Mohan A, Meyers CA, et al. Vascular patterning in human heterotopic ossification. Hum Pathol. 2017;63:165–70.
    1. Kempson RL, Armed Forces Institute of Pathology, Universities Associated for Research and Education in Pathology. Tumors of the soft tissues. Washington, DC: Armed Forces Institute of Pathology; 2001.
    1. Luczynska E, Kasperkiewicz H, Domalik A, Cwierz A, Bobek‐Billewicz B. Myositis ossificans mimicking sarcoma, the importance of diagnostic imaging—case report. Pol J Radiol. 2014;79:228–32.
    1. Patel RM, Weiss SW, Folpe AL. Heterotopic mesenteric ossification: a distinctive pseudosarcoma commonly associated with intestinal obstruction. Am J Surg Pathol. 2006;30 (1):119–22.
    1. Magne D, Bougault C. What understanding tendon cell differentiation can teach us about pathological tendon ossification. Histol Histopathol. 2015;30 (8):901–10.
    1. Richards PJ, Braid JC, Carmont MR, Maffulli N. Achilles tendon ossification: pathology, imaging and aetiology. Disabil Rehabil. 2008;30(20–22):1651–65.
    1. Weinreb JH, Sheth C, Apostolakos J, et al. Tendon structure, disease, and imaging. Muscles Ligaments Tendons J. 2014;4 (1):66–73.
    1. Fisher TR, Woods CG. Partial rupture of the tendo calcaneus with heterotopic ossification. Report of a case. J Bone Joint Surg Br. 1970;52 (2):334–6.
    1. Postacchini F, Di Castro A. Subtotal ossification of the Achilles tendon. Case report. Ital J Orthop Traumatol. 1983;9 (4):529–32.
    1. Sobel E, Giorgini R, Hilfer J, Rostkowski T. Ossification of a ruptured achilles tendon: a case report in a diabetic patient. J Foot Ankle Surg. 2002;41 (5):330–4.
    1. Hatori M, Kita A, Hashimoto Y, Watanabe N, Sakurai M. Ossification of the Achilles tendon: a case report. Foot Ankle Int. 1994;15 (1):44–7.
    1. Kisgen H. Ueber tendinitis ossificans traumatica. 1925.
    1. Blitz E, Sharir A, Akiyama H, Zelzer E. Tendon‐bone attachment unit is formed modularly by a distinct pool of Scx‐ and Sox9‐positive progenitors. Development. 2013;140(13):2680–90.
    1. Foley KL, Hebela N, Keenan MA, Pignolo RJ. Histopathology of periarticular non‐hereditary heterotopic ossification. Bone. 2018;109:65–70.
    1. Peterson JR, Agarwal S, Brownley RC, et al. Direct mouse trauma/burn model of heterotopic ossification. J Vis Exp. 2015(102):e52880.
    1. Peterson JR, De La Rosa S, Sun H, et al. Burn injury enhances bone formation in heterotopic ossification model. Ann Surg. 2014;259(5):993–8.
    1. Fiamengo SA, Warren RF, Marshall JL, Vigorita VT, Hersh A. Posterior heel pain associated with a calcaneal step and Achilles tendon calcification. Clin Orthop Relat Res. 1982(167):203–11.
    1. Foley KL, Hebela N, Keenan MA, Pignolo RJ. Histopathology of periarticular non‐hereditary heterotopic ossification. Bone. 2018;109:65–70.
    1. Dubansky BH, Dubansky BD. Natural development of dermal ectopic bone in the american alligator (Alligator mississippiensis) resembles heterotopic ossification disorders in humans. Anat Rec (Hoboken). 2018;301 (1):56–76.
    1. Convente MR, Wang H, Pignolo RJ, Kaplan FS, Shore EM. The immunological contribution to heterotopic ossification disorders. Curr Osteoporos Rep. 2015;13 (2):116–24.
    1. Shore EM, Kaplan FS. Inherited human diseases of heterotopic bone formation. Nat Rev Rheumatol. 2010;6 (9):518–27.
    1. Riegler HF, Harris CM. Heterotopic bone formation after total hip arthroplasty. Clin Orthop Relat Res. 1976(117):209–16.
    1. Kienapfel H, Koller M, Wust A, et al. Prevention of heterotopic bone formation after total hip arthroplasty: a prospective randomised study comparing postoperative radiation therapy with indomethacin medication. Arch Orthop Trauma Surg. 1999;119(5–6):296–302.
    1. Firoozabadi R, O'Mara TJ, Swenson A, Agel J, Beck JD, Routt M. Risk factors for the development of heterotopic ossification after acetabular fracture fixation. Clin Orthop Relat Res. 2014;472 (11):3383–8.
    1. Hurlimann M, Schiapparelli FF, Rotigliano N, Testa E, Amsler F, Hirschmann MT. Influence of surgical approach on heterotopic ossification after total hip arthroplasty—is minimal invasive better? A case control study. BMC Musculoskelet Disord. 2017;18(1):27.
    1. Biz C, Pavan D, Frizziero A, Baban A, Iacobellis C. Heterotopic ossification following hip arthroplasty: a comparative radiographic study about its development with the use of three different kinds of implants. J Orthop Surg Res. 2015;10:176.
    1. Rath EM, Russell GV Jr, Washington WJ, Routt ML Jr. Gluteus minimus necrotic muscle debridement diminishes heterotopic ossification after acetabular fracture fixation. Injury. 2002;33 (9):751–6.
    1. Sagi HC, Jordan CJ, Barei DP, Serrano‐Riera R, Steverson B. Indomethacin prophylaxis for heterotopic ossification after acetabular fracture surgery increases the risk for nonunion of the posterior wall. J Orthop Trauma. 2014;28 (7):377–83.
    1. Guo JJ, Tang N, Yang HL, Qin L, Leung KS. Impact of surgical approach on postoperative heterotopic ossification and avascular necrosis in femoral head fractures: a systematic review. Int Orthop. 2010;34(3):319–22.
    1. Qureshi AT, Crump EK, Pavey GJ, Hope DN, Forsberg JA, Davis TA. Early characterization of blast‐related heterotopic ossification in a rat model. Clin Orthop Relat Res. 2015;473 (9):2831–9.
    1. Sullivan MP, Torres SJ, Mehta S, Ahn J. Heterotopic ossification after central nervous system trauma: a current review. Bone Joint Res. 2013;2 (3):51–7.
    1. Ranganathan K, Loder S, Agarwal S, et al. Heterotopic ossification: basic‐science principles and clinical correlates. J Bone Joint Surg Am. 2015;97(13):1101–11.
    1. Reichel LM, Salisbury E, Moustoukas MJ, Davis AR, Olmsted‐Davis E. Molecular mechanisms of heterotopic ossification. J Hand Surg Am. 2014;39 (3):563–6.
    1. Madsen JE, Hukkanen M, Aune AK, et al. Fracture healing and callus innervation after peripheral nerve resection in rats. Clin Orthop Relat Res. 1998(351):230–40.
    1. Garcés GL, Santandreu ME. Longitudinal bone growth after sciatic denervation in rats. J Bone Joint Surg Br. 1988;70 (2):315–8.
    1. Offley SC, Guo TZ, Wei T, et al. Capsaicin‐sensitive sensory neurons contribute to the maintenance of trabecular bone integrity. J Bone Miner Res. 2005;20 (2):257–67.
    1. Heffner MA, Anderson MJ, Yeh GC, Genetos DC, Christiansen BA. Altered bone development in a mouse model of peripheral sensory nerve inactivation. J Musculoskelet Neuronal Interact. 2014;14 (1):1–9.
    1. Genet F, Kulina I, Vaquette C, et al. Neurological heterotopic ossification following spinal cord injury is triggered by macrophage‐mediated inflammation in muscle. J Pathol. 2015;236 (2):229–40.
    1. Medina A, Shankowsky H, Savaryn B, Shukalak B, Tredget EE. Characterization of heterotopic ossification in burn patients. J Burn Care Res. 2014;35 (3):251–6.
    1. Winkler S, Wagner F, Weber M, et al. Current therapeutic strategies of heterotopic ossification––a survey amongst orthopaedic and trauma departments in Germany. BMC Musculoskelet Disord. 2015;16:313.
    1. Popovic M, Agarwal A, Zhang L, et al. Radiotherapy for the prophylaxis of heterotopic ossification: a systematic review and meta‐analysis of published data. Radiother Oncol. 2014;113 (1):10–7.
    1. Liu JZ, Frisch NB, Barden RM, Rosenberg AG, Silverton CD, Galante JO. Heterotopic ossification prophylaxis after total hip arthroplasty: randomized trial of 400 vs 700 cGy. J Arthroplasty. 2017;32 (4):1328–34.
    1. Milakovic M, Popovic M, Raman S, Tsao M, Lam H, Chow E. Radiotherapy for the prophylaxis of heterotopic ossification: a systematic review and meta‐analysis of randomized controlled trials. Radiother Oncol. 2015;116(1):4–9.
    1. Seegenschmiedt MH, Makoski HB, Micke O, German Cooperative Group on Radiotherapy for Benign D. Radiation prophylaxis for heterotopic ossification about the hip joint–a multicenter study. Int J Radiat Oncol Biol Phys. 2001;51 (3):756–65.
    1. Mishra MV, Austin L, Parvizi J, Ramsey M, Showalter TN. Safety and efficacy of radiation therapy as secondary prophylaxis for heterotopic ossification of non‐hip joints. J Med Imaging Radiat Oncol. 2011;55(3):333–6.
    1. Museler AC, Grasmucke D, Jansen O, et al. In‐hospital outcomes following single‐dose radiation therapy in the treatment of heterotopic ossification of the hip following spinal cord injury—an analysis of 444 cases. Spinal Cord. 2017;55 (3):244–6.
    1. Ploumis A, Belbasis L, Ntzani E, Tsekeris P, Xenakis T. Radiotherapy for prevention of heterotopic ossification of the elbow: a systematic review of the literature. J Shoulder Elbow Surg. 2013;22 (11):1580–8.
    1. Hamid N, Ashraf N, Bosse MJ, et al. Radiation therapy for heterotopic ossification prophylaxis acutely after elbow trauma: a prospective randomized study. J Bone Joint Surg Am. 2010;92 (11):2032–8.
    1. Sheybani A, TenNapel MJ, Lack WD, et al. Risk of radiation‐induced malignancy with heterotopic ossification prophylaxis: a case‐control analysis. Int J Radiat Oncol Biol Phys. 2014;89 (3):584–9.
    1. Mazonakis M, Berris T, Lyraraki E, Damilakis J. Cancer risk estimates from radiation therapy for heterotopic ossification prophylaxis after total hip arthroplasty. Med Phys. 2013;40 (10):101702.
    1. Ritter MA, Sieber JM. Prophylactic indomethacin for the prevention of heterotopic bone formation following total hip arthroplasty. Clin Orthop Relat Res. 1985(196):217–25.
    1. Moore KD, Goss K, Anglen JO. Indomethacin versus radiation therapy for prophylaxis against heterotopic ossification in acetabular fractures: a randomised, prospective study. J Bone Joint Surg Br. 1998;80 (2):259–63.
    1. Oni JK, Pinero JR, Saltzman BM, Jaffe FF. Effect of a selective COX‐2 inhibitor, celecoxib, on heterotopic ossification after total hip arthroplasty: a case‐controlled study. Hip Int. 2014;24 (3):256–62.
    1. Vasileiadis GI, Sioutis IC, Mavrogenis AF, Vlasis K, Babis GC, Papagelopoulos PJ. COX‐2 inhibitors for the prevention of heterotopic ossification after THA. Orthopedics. 2011;34 (6):467.
    1. Beckmann JT, Wylie JD, Potter MQ, Maak TG, Greene TH, Aoki SK. Effect of naproxen prophylaxis on heterotopic ossification following hip arthroscopy: a double‐blind randomized placebo‐controlled trial. J Bone Joint Surg Am. 2015;97(24):2032–7.
    1. Banovac K, Williams JM, Patrick LD, Levi A. Prevention of heterotopic ossification after spinal cord injury with COX‐2 selective inhibitor (rofecoxib). Spinal Cord. 2004;42 (12):707–10.
    1. Sun Y, Cai J, Li F, Liu S, Ruan H, Fan C. The efficacy of celecoxib in preventing heterotopic ossification recurrence after open arthrolysis for post‐traumatic elbow stiffness in adults. J Shoulder Elbow Surg. 2015;24 (11):1735–40.
    1. Vavken P, Dorotka R. Economic evaluation of NSAID and radiation to prevent heterotopic ossification after hip surgery. Arch Orthop Trauma Surg. 2011;131(9):1309–15.
    1. The medical management of FOP: current treatment considerations. In: Kaplan FS, Shore EM, Pignolo RJ, editors. The International Consortium on FOP. Philadelphia: The Center for Research in FOP and Related Disorders, The University of Pennsylvania, School of Medicine; 2011. p. 1–100.
    1. Nollen AJ. Effects of ethylhydroxydiphosphonate (EHDP) on heterotopic ossification. Acta Orthop Scand. 1986;57 (4):358–61.
    1. Shafer DM, Bay C, Caruso DM, Foster KN. The use of eidronate disodium in the prevention of heterotopic ossification in burn patients. Burns. 2008;34 (3):355–60.
    1. Thomas BJ, Amstutz HC. Results of the administration of diphosphonate for the prevention of heterotopic ossification after total hip arthroplasty. J Bone Joint Surg Am. 1985;67 (3):400–3.
    1. Shimono K, Tung WE, Macolino C, et al. Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor‐gamma agonists. Nat Med. 2011;17 (4):454–60.
    1. Pavlou G, Kyrkos M, Tsialogiannis E, Korres N, Tsiridis E. Pharmacological treatment of heterotopic ossification following hip surgery: an update. Expert Opin Pharmacother. 2012;13 (5):619–22.
    1. Aronen JG, Garrick JG, Chronister RD, McDevitt ER. Quadriceps contusions: clinical results of immediate immobilization in 120 degrees of knee flexion. Clin J Sport Med. 2006;16 (5):383–7.
    1. Pavey GJ, Polfer EM, Nappo KE, Tintle SM, Forsberg JA, Potter BK. What risk factors predict recurrence of heterotopic ossification after excision in combat‐related amputations? Clin Orthop Relat Res. 2015;473 (9):2814–24.
    1. Almangour W, Schnitzler A, Salga M, Debaud C, Denormandie P, Genet F. Recurrence of heterotopic ossification after removal in patients with traumatic brain injury: a systematic review. Ann Phys Rehabil Med. 2016;59 (4):263–9.
    1. Chen S, Yu SY, Yan H, et al. The time point in surgical excision of heterotopic ossification of post‐traumatic stiff elbow: recommendation for early excision followed by early exercise. J Shoulder Elbow Surg. 2015;24 (8):1165–71.
    1. Brouwer KM, Lindenhovius AL, de Witte PB, Jupiter JB, Ring D. Resection of heterotopic ossification of the elbow: a comparison of ankylosis and partial restriction. J Hand Surg Am. 2010;35(7):1115–9.
    1. Hatsell SJ, Idone V, Wolken DM, et al. ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A. Sci Transl Med. 2015;7 (303):303ra137.
    1. Lees‐Shepard JB, Yamamoto M, Biswas AA, et al. Activin‐dependent signaling in fibro/adipogenic progenitors causes fibrodysplasia ossificans progressiva. Nat Commun. 2018;9 (1):471.
    1. Chakkalakal SA, Uchibe K, Convente MR, et al. palovarotene inhibits heterotopic ossification and maintains limb mobility and growth in mice with the human ACVR1(R206H) fibrodysplasia ossificans progressiva (FOP) mutation. J Bone Miner Res. 2016;31 (9):1666–75.
    1. Yu PB, Deng DY, Lai CS, et al. BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat Med. 2008;14 (12):1363–9.
    1. O'Connor PJ. Animal models of heterotopic ossification. Clin Orthop Relat Res. 1998;346:71–80.
    1. Schneider DJ, Moulton MJ, Singapuri K, et al. The Frank Stinchfield Award. Inhibition of heterotopic ossification with radiation therapy in an animal model. Clin Orthop Relat Res. 1998(355):35–46.
    1. Rumi MN, Deol GS, Singapuri KP, Pellegrini VD Jr. The origin of osteoprogenitor cells responsible for heterotopic ossification following hip surgery: an animal model in the rabbit. J Orthop Res. 2005;23 (1):34–40.
    1. Yano M, Kawao N, Okumoto K, Tamura Y, Okada K, Kaji H. Fibrodysplasia ossificans progressiva‐related activated activin‐like kinase signaling enhances osteoclast formation during heterotopic ossification in muscle tissues. J Biol Chem. 2014;289 (24):16966–77.
    1. Scott MA, Levi B, Askarinam A, et al. Brief review of models of ectopic bone formation. Stem Cells Dev. 2012;21 (5):655–67.
    1. Hamilton PT, Jansen MS, Ganesan S, et al. Improved bone morphogenetic protein‐2 retention in an injectable collagen matrix using bifunctional peptides. PLoS One. 2013;8 (8):e70715.
    1. Lounev VY, Ramachandran R, Wosczyna MN, et al. Identification of progenitor cells that contribute to heterotopic skeletogenesis. J Bone Joint Surg Am. 2009;91 (3):652–63.
    1. Liu X, Kang H, Shahnazari M, et al. A novel mouse model of trauma induced heterotopic ossification. J Orthop Res. 2014;32 (2):183–8.
    1. James AW, Zara JN, Zhang X, et al. Perivascular stem cells: a prospectively purified mesenchymal stem cell population for bone tissue engineering. Stem Cells Transl Med. 2012;1 (6):510–9.
    1. Leblanc E, Trensz F, Haroun S, et al. BMP‐9‐induced muscle heterotopic ossification requires changes to the skeletal muscle microenvironment. J Bone Miner Res. 2011;26 (6):1166–77.
    1. Kan L, Hu M, Gomes WA, Kessler JA. Transgenic mice overexpressing BMP4 develop a fibrodysplasia ossificans progressiva (FOP)‐like phenotype. Am J Pathol. 2004;165 (4):1107–15.
    1. Agarwal S, Loder SJ, Sorkin M, et al. Analysis of bone‐cartilage‐stromal progenitor populations in trauma induced and genetic models of heterotopic ossification. Stem Cells. 2016;34(6):1692–701.
    1. Heffner CS, Herbert Pratt C, Babiuk RP, et al. Supporting conditional mouse mutagenesis with a comprehensive cre characterization resource. Nat Commun. 2012;3:1218.
    1. Dey D, Bagarova J, Hatsell SJ, et al. Two tissue‐resident progenitor lineages drive distinct phenotypes of heterotopic ossification. Sci Transl Med. 2016;8 (366):366ra163.
    1. Agarwal S, Loder SJ, Cholok D, et al. Scleraxis‐lineage cells contribute to ectopic bone formation in muscle and tendon. Stem Cells. 2017;35 (3):705–10.
    1. Agarwal S, Loder S, Brownley C, et al. Inhibition of Hif1alpha prevents both trauma‐induced and genetic heterotopic ossification. Proc Natl Acad Sci U S A. 2016;113 (3):E338–47.
    1. Agarwal S, Loder SJ, Brownley C, et al. BMP signaling mediated by constitutively active Activin type 1 receptor (ACVR1) results in ectopic bone formation localized to distal extremity joints. Dev Biol. 2015;400 (2):202–9.
    1. Kan L, Peng CY, McGuire TL, Kessler JA. Glast‐expressing progenitor cells contribute to heterotopic ossification. Bone. 2013;53 (1):194–203.
    1. Olmsted‐Davis EA, Salisbury EA, Hoang D, et al. Progenitors in peripheral nerves launch heterotopic ossification. Stem Cells Transl Med. 2017;6 (4):1109–19.
    1. Medici D, Shore EM, Lounev VY, Kaplan FS, Kalluri R, Olsen BR. Conversion of vascular endothelial cells into multipotent stem‐like cells. Nat Med. 2010;16 (12):1400–6.
    1. Wosczyna MN, Biswas AA, Cogswell CA, Goldhamer DJ. Multipotent progenitors resident in the skeletal muscle interstitium exhibit robust BMP‐dependent osteogenic activity and mediate heterotopic ossification. J Bone Miner Res. 2012;27 (5):1004–17.
    1. Suda RK, Billings PC, Egan KP, et al. Circulating osteogenic precursor cells in heterotopic bone formation. Stem Cells. 2009;27 (9):2209–19.
    1. Kaplan FS, Glaser DL, Shore EM, et al. Hematopoietic stem‐cell contribution to ectopic skeletogenesis. J Bone Joint Surg Am. 2007;89 (2):347–57.
    1. Egan KP, Kim JH, Mohler ER 3rd, Pignolo RJ. Role for circulating osteogenic precursor cells in aortic valvular disease. Arterioscler Thromb Vasc Biol. 2011;31 (12):2965–71.
    1. Otsuru S, Overholt KM, Olson TS, et al. Hematopoietic derived cells do not contribute to osteogenesis as osteoblasts. Bone. 2017;94:1–9.
    1. Kan L, Liu Y, McGuire TL, et al. Dysregulation of local stem/progenitor cells as a common cellular mechanism for heterotopic ossification. Stem Cells. 2009;27 (1):150–6.
    1. Simon JP, Maes M, Robbens E, Bellemans J. Total hip arthroplasty in inflammatory arthritis in patients under 35 years. A 7 to 19 year follow‐up. Hip Int. 2010;20 (2):163–70.
    1. Wang D, Wang S, Huang X, Wang Q. Heterotopic ossification following anti‐NMDA receptor encephalitis: a case report. BMC Neurol. 2016;16 (1):232.
    1. Zeilig G, Weingarden HP, Levy R, Peer I, Ohry A, Blumen N. Heterotopic ossification in Guillain‐Barre syndrome: incidence and effects on functional outcome with long‐term follow‐up. Arch Phys Med Rehabil. 2006;87 (1):92–5.
    1. Chalmers J, Gray DH, Rush J. Observations on the induction of bone in soft tissues. J Bone Joint Surg Br. 1975;57 (1):36–45.
    1. Elmstedt E, Lindholm TS, Nilsson OS, Tornkvist H. Effect of ibuprofen on heterotopic ossification after hip replacement. Acta Orthop Scand. 1985;56 (1):25–7.
    1. Kraft CT, Agarwal S, Ranganathan K, et al. Trauma‐induced heterotopic bone formation and the role of the immune system: a review. J Trauma Acute Care Surg. 2016;80 (1):156–65.
    1. Chakkalakal SA, Zhang D, Culbert AL, et al. An Acvr1 R206H knock‐in mouse has fibrodysplasia ossificans progressiva. J Bone Miner Res. 2012;27 (8):1746–56.
    1. Convente MR, Chakkalakal SA, Yang E, et al. Depletion of mast cells and macrophages impairs heterotopic ossification in an Acvr1(R206H) mouse model of fibrodysplasia ossificans progressiva. J Bone Miner Res. 2018;33 (2):269–82.
    1. Torossian F, Guerton B, Anginot A, et al. Macrophage‐derived oncostatin M contributes to human and mouse neurogenic heterotopic ossifications. JCI Insight. 2017;2(21).
    1. Gannon FH, Glaser D, Caron R, Thompson LD, Shore EM, Kaplan FS. Mast cell involvement in fibrodysplasia ossificans progressiva. Hum Pathol. 2001;32 (8):842–8.
    1. Brennan TA, Lindborg CM, Bergbauer CR, Wang H, Kaplan FS, Pignolo RJ. Mast cell inhibition as a therapeutic approach in fibrodysplasia ossificans progressiva (FOP). Bone. 2018;109:259–66.
    1. Steiner I, Kasparova P, Kohout A, Dominik J. Bone formation in cardiac valves: a histopathological study of 128 cases. Virchows Arch. 2007;450 (6):653–7.
    1. Mohler ER 3rd, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation. 2001;103 (11):1522–8.
    1. Ranganathan K, Agarwal S, Cholok D, et al. The role of the adaptive immune system in burn‐induced heterotopic ossification and mesenchymal cell osteogenic differentiation. J Surg Res. 2016;206 (1):53–61.
    1. Kaplan FS, Pignolo RJ, Shore EM. Granting immunity to FOP and catching heterotopic ossification in the Act. Semin Cell Dev Biol. 2016;49:30–6.
    1. Hoff P, Rakow A, Gaber T, et al. Preoperative irradiation for the prevention of heterotopic ossification induces local inflammation in humans. Bone. 2013;55 (1):93–101.
    1. Sung Hsieh HH, Chung MT, Allen RM, et al. Evaluation of salivary cytokines for diagnosis of both trauma‐induced and genetic heterotopic ossification. Front Endocrinol (Lausanne). 2017;8:74.
    1. Evans KN, Forsberg JA, Potter BK, et al. Inflammatory cytokine and chemokine expression is associated with heterotopic ossification in high‐energy penetrating war injuries. J Orthop Trauma. 2012;26 (11):e204–13.
    1. Forsberg JA, Potter BK, Polfer EM, Safford SD, Elster EA. Do inflammatory markers portend heterotopic ossification and wound failure in combat wounds? Clin Orthop Relat Res. 2014;472(9):2845–54.
    1. Hildebrand L, Gaber T, Kuhnen P, et al. Trace element and cytokine concentrations in patients with fibrodysplasia ossificans progressiva (FOP): a case control study. J Trace Elem Med Biol. 2017;39:186–92.
    1. Peterson JR, De La Rosa S, Eboda O, et al. Treatment of heterotopic ossification through remote ATP hydrolysis. Sci Transl Med. 2014;6(255):255ra132.
    1. Qureshi AT, Dey D, Sanders EM, et al. Inhibition of mammalian target of rapamycin signaling with rapamycin prevents trauma‐induced heterotopic ossification. Am J Pathol. 2017;187 (11):2536–45.
    1. Hino K, Horigome K, Nishio M, et al. Activin‐A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva. J Clin Invest. 2017;127 (9):3339–52.
    1. Kan L, Lounev VY, Pignolo RJ, et al. Substance P signaling mediates BMP‐dependent heterotopic ossification. J Cell Biochem. 2011;112 (10):2759–72.
    1. Tuzmen C, Verdelis K, Weiss L, Campbell P. Crosstalk between substance P and calcitonin gene‐related peptide during heterotopic ossification in murine Achilles tendon. J Orthop Res. 2018;36 (5):1444–55.
    1. Urist MR. Bone: formation by autoinduction. Science. 1965;150 (3698):893–9.
    1. Salisbury E, Rodenberg E, Sonnet C, et al. Sensory nerve induced inflammation contributes to heterotopic ossification. J Cell Biochem. 2011;112 (10):2748–58.
    1. Hannallah D, Peng H, Young B, Usas A, Gearhart B, Huard J. Retroviral delivery of Noggin inhibits the formation of heterotopic ossification induced by BMP‐4, demineralized bone matrix, and trauma in an animal model. J Bone Joint Surg Am. 2004;86‐A(1):80–91.
    1. van Dinther M, Visser N, de Gorter DJ, et al. ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP‐induced osteoblast differentiation and bone formation. J Bone Miner Res. 2010;25 (6):1208–15.
    1. Upadhyay J, Xie L, Huang L, et al. The expansion of heterotopic bone in fibrodysplasia ossificans progressiva is activin A‐dependent. J Bone Miner Res. 2017;32 (12):2489–99.
    1. Phornphutkul C, Wu KY, Auyeung V, Chen Q, Gruppuso PA. mTOR signaling contributes to chondrocyte differentiation. Dev Dyn. 2008;237 (3):702–12.
    1. Laplante M, Sabatini DM. mTOR signaling at a glance. J Cell Sci. 2009;122(Pt 20):3589–94.
    1. Jiang H, Chen Y, Chen G, et al. Leptin accelerates the pathogenesis of heterotopic ossification in rat tendon tissues via mTORC1 signaling. J Cell Physiol. 2018;233 (2):1017–28.
    1. Semenza GL. Hypoxia‐inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med. 2001;7 (8):345–50.
    1. Wang Y, Wan C, Deng L, et al. The hypoxia‐inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest. 2007;117 (6):1616–26.
    1. Dilling CF, Wada AM, Lazard ZW, et al. Vessel formation is induced prior to the appearance of cartilage in BMP‐2‐mediated heterotopic ossification. J Bone Miner Res. 2010;25 (5):1147–56.
    1. Zimmermann SM, Wurgler‐Hauri CC, Wanner GA, Simmen HP, Werner CM. Echinomycin in the prevention of heterotopic ossification—an experimental antibiotic agent shows promising results in a murine model. Injury. 2013;44 (4):570–5.
    1. Wang H, Lindborg C, Lounev V, et al. Cellular hypoxia promotes heterotopic ossification by amplifying BMP signaling. J Bone Miner Res. 2016;31 (9):1652–65.
    1. Lin L, Shen Q, Leng H, Duan X, Fu X, Yu C. Synergistic inhibition of endochondral bone formation by silencing Hif1alpha and Runx2 in trauma‐induced heterotopic ossification. Mol Ther. 2011;19 (8):1426–32.
    1. Galdones E, Hales BF. Retinoic acid receptor gamma‐induced misregulation of chondrogenesis in the murine limb bud in vitro. Toxicol Sci. 2008;106 (1):223–32.
    1. Romand R, Hashino E, Dollé P, Vonesch JL, Chambon P, Ghyselinck NB. The retinoic acid receptors RARalpha and RARgamma are required for inner ear development. Mech Dev. 2002;119 (2):213–23.
    1. Weston AD, Chandraratna RA, Torchia J, Underhill TM. Requirement for RAR‐mediated gene repression in skeletal progenitor differentiation. J Cell Biol. 2002;158 (1):39–51.
    1. Weston AD, Rosen V, Chandraratna RA, Underhill TM. Regulation of skeletal progenitor differentiation by the BMP and retinoid signaling pathways. J Cell Biol. 2000;148 (4):679–90.
    1. Cash DE, Bock CB, Schughart K, Linney E, Underhill TM. Retinoic acid receptor alpha function in vertebrate limb skeletogenesis: a modulator of chondrogenesis. J Cell Biol. 1997;136 (2):445–57.
    1. Shimono K, Morrison TN, Tung WE, et al. Inhibition of ectopic bone formation by a selective retinoic acid receptor alpha‐agonist: a new therapy for heterotopic ossification? J Orthop Res. 2010;28 (2):271–7.
    1. Lees‐Shepard JB, Nicholas SE, Stoessel SJ, et al. Palovarotene reduces heterotopic ossification in juvenile FOP mice but exhibits pronounced skeletal toxicity. Elife. 2018;7.
    1. Pavey GJ, Qureshi AT, Tomasino AM, et al. Targeted stimulation of retinoic acid receptor‐gamma mitigates the formation of heterotopic ossification in an established blast‐related traumatic injury model. Bone. 2016;90:159–67.
    1. Tolo V, Feldman D, Ackman J, et al. An efficacy and safety study of palovarotene for the treatment of MO (MO‐Ped). Bethesda, MD: US National Institutes of Health; 2018.
    1. Walewicz J, Alicia D. Clementia announces completion of enrollment in phase 3 MOVE trial for FOP. Montreal, Canada: Clementia Pharmaceuticals; 2018.
    1. Regard JB, Malhotra D, Gvozdenovic‐Jeremic J, et al. Activation of Hedgehog signaling by loss of GNAS causes heterotopic ossification. Nat Med. 2013;19 (11):1505–12.
    1. Kan C, Chen L, Hu Y, et al. Gli1‐labeled adult mesenchymal stem/progenitor cells and hedgehog signaling contribute to endochondral heterotopic ossification. Bone. 2018;109:71–9.
    1. Agarwal S, Loder SJ, Brownley C, et al. BMP signaling mediated by constitutively active Activin type 1 receptor (ACVR1) results in ectopic bone formation localized to distal extremity joints. Dev Biol. 2015;400 (2):202–9.
    1. Louney V, Kaplan VFS, Shore EM. Lack of pericyte contribution to BMP4‐induced heterotopic ossification. ASBMR; 2010.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅